Cargando…

Metformin does not slow cyst growth in the PCK rat model of polycystic kidney disease

Metformin (MET) has the potential to activate p‐AMPK and block mTORC1‐induced proliferation of tubular cells in PKD kidneys. The aim of this study was to determine the effects of MET on cyst growth, kidney function, AMPK and mTOR signaling, and lactate levels in male PCK rats, a Pkhd1 gene mutation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oto, Ozgur A., Atwood, Daniel J., Chaudhary, Anjana, He, Zhibin, Li, Amy S., Wempe, Michael F., Edelstein, Charles L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471794/ https://www.ncbi.nlm.nih.gov/pubmed/37653564 http://dx.doi.org/10.14814/phy2.15776

Ejemplares similares

Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats
por: Kapoor, Sarika, et al.
Publicado: (2015)

Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
por: Leonhard, Wouter N., et al.
Publicado: (2019)

Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease
por: Blazer-Yost, Bonnie L., et al.
Publicado: (2010)

Collagen-driven remodeling of the intrahepatic duct wall in the PCK rat model of polycystic kidney disease-Caroli syndrome
por: Narayan, Rithika, et al.
Publicado: (2020)

Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency
por: Li, Zheng, et al.
Publicado: (2022)

Impaired epithelial Na(+) channels activity contributes to cystogenesis and development of autosomal recessive polycystic kidney disease in PCK rats
por: Pavlov, Tengis S., et al.
Publicado: (2014)

Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease
por: Kugita, Masanori, et al.
Publicado: (2017)

A case report of pre-eclampsia-like endothelial injury in the kidney of an 85-year-old man treated with ibrutinib
por: Li, Amy, et al.
Publicado: (2022)

Increased salt intake does not worsen the progression of renal cystic disease in high water-loaded PCK rats
por: Nagao, Shizuko, et al.
Publicado: (2019)

Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
por: Kim, Hyun-Jung, et al.
Publicado: (2012)

Evaluation of urine biomarkers of kidney injury in Polycystic Kidney Disease
por: Parikh, Chirag R., et al.
Publicado: (2012)

Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts
por: Hamanoue, Satoshi, et al.
Publicado: (2018)

Sacral radicular cysts in autosomal dominant polycystic kidney disease
por: Peces, Ramón, et al.
Publicado: (2009)

Quinomycin A reduces cyst progression in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Multiple Cysts in the Kidney and Lungs in a Patient with Polycystic Kidney Disease and Lymphangioleiomyomatosis
por: Lam, Anna P., et al.
Publicado: (2007)

Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease
por: Magistroni, Riccardo
Publicado: (2018)

Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?
por: Pisani, Antonio, et al.
Publicado: (2018)

Vascular Calcification Slows But Does Not Regress After Kidney Transplantation
por: Alappan, Harish R., et al.
Publicado: (2020)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
por: Matsuura, Ryo, et al.
Publicado: (2016)

Emerging roles of cytosolic phosphoenolpyruvate kinase 1 (PCK1) in cancer
por: Abate, Ebsitu, et al.
Publicado: (2023)

Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease
por: Klawitter, Jelena, et al.
Publicado: (2013)

Choledochal Cyst Associated With Polycystic Kidney Disease: Report of a Case
por: Hasegawa, T., et al.
Publicado: (1999)

Intraperitoneal rupture of renal cyst in autosomal dominant polycystic kidney disease
por: Hammami, Mohamed, et al.
Publicado: (2010)

Autophagy induction promotes renal cyst growth in polycystic kidney disease
por: Lee, Eun Ji, et al.
Publicado: (2020)

Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease
por: Karner, Larina A., et al.
Publicado: (2022)

Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease
por: Zhang, Jennifer Q. J., et al.
Publicado: (2021)

Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice
por: Geng, Guangrui, et al.
Publicado: (2020)

Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022)

Does erythropoietin slow progression of chronic kidney disease?
por: Nasri, Hamid, et al.
Publicado: (2013)

Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease
por: Wallace, Darren P., et al.
Publicado: (2013)

Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease
por: Lee, Seung Hun, et al.
Publicado: (2014)

Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
por: Ishimoto, Yu, et al.
Publicado: (2017)

Type IV choledochal cyst with polycystic kidney disease: a case report
por: He, Yuxin, et al.
Publicado: (2020)

Cyst Reduction by Melatonin in a Novel Drosophila Model of Polycystic Kidney Disease
por: Millet-Boureima, Cassandra, et al.
Publicado: (2020)

Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
por: Ren, Xiang Shan, et al.
Publicado: (2014)

Chronic Exercise Protects against the Progression of Renal Cyst Growth and Dysfunction in Rats with Polycystic Kidney Disease
por: QIU, JIAHE, et al.
Publicado: (2021)

Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease
por: Arkhipov, Sergey N., et al.
Publicado: (2023)

A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease
por: Sorohan, Bogdan Marian, et al.
Publicado: (2019)

Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease
por: Ta, Michelle H. T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tp50496b1g5ta22jjsi8le4u7t